Nav: Home

HKU AIDS Institute invents universal antibody drug for HIV-1 prevention and immunotherapy

May 07, 2018

A research team led by scientists at AIDS Institute and Department of Microbiology, Li Ka Shing Faculty of Medicine of The University of Hong Kong (HKU) invents a universal antibody drug against HIV/AIDS. By engineering a tandem bi-specific broadly neutralizing antibody, the team found that this novel antibody drug is universally effective not only against all genetically divergent global HIV-1 strains tested but also promoting the elimination of latently infected cells in a humanized mouse model. The new findings are now published in the April issue of Journal of Clinical Investigation, one of the world's leading biomedical journals. (link to the publication).

Background

AIDS remains an incurable disease. In the world, HIV/AIDS has resulted in estimated 40 million deaths while 36.9 million people are still living with the virus. To end the HIV/AIDS pandemic, it is important to discover either an effective vaccine or a therapeutic cure. There are, however, two major scientific challenges: the tremendous HIV-1 diversity and the antiviral drug-unreachable latency. Since it is extremely difficult to develop an appropriate immunogen to elicit broadly neutralizing antibodies (bnAbs) against genetically divergent HIV-1 subtypes, developing existing bnAbs as passive immunization becomes a useful approach for HIV-1 prophylaxis and immunotherapy.

Previous studies have investigated the potency, breadth and crystal structure of many bnAbs including their combination both in vitro and in vivo. Naturally occurring HIV-1 resistant strains, however, are readily found against these so-called bnAbs and result in the failure of durable viral suppression in bnAb-based monotherapy. To improve HIV-1 neutralization breadth and potency, bispecific bnAb, which blocks two essential steps of HIV-1 entry into target cells, have been engineered and show promising efficacy in animal models. Before the publication, tandem bi-specific bnAb has not been previously investigated in vivo against HIV-1 infection.

Research method and findings

The HKU research team invented a single gene-encoded tandem broadly neutralizing antibody, titled "BiIA-SG", which "kills two birds with one stone". By attaching to host protein CD4, BiIA-SG strategically ambushes invading HIV-1 particles to protect CD4 positive T cells. BiIA-SG not only displays a potent activity against all three panels of 124 genetically divergent global HIV-1 strains tested, but also prevents diverse live viral challenges completely in humanized mice. Moreover, gene transfer of BiIA-SG achieves pro-longed drug availability in vivo, leading to a promising efficacy of eliminating HIV-1 infected cells in humanized mice. Therefore, the research team provides a proof-of-concept that BiIA-SG is a novel universal antibody drug for prevention and immunotherapy against HIV-1 infection.

Significance of the study

The accumulated number of HIV-1 infections has more than doubled from 4,443 diagnostic cases in 2009 to 9,091 in 2017, despite the timely introduced combination antiretroviral therapy and prevention interventions in Hong Kong. Currently, the estimated annual cost is over HK$550 millions for antiretroviral drugs alone per year in Hong Kong, not to mention the rising issues of life-long financial burdens, drug toxicity and resistant viruses. The newly invented universal antibody drug brings the hope to fight these issues. With significantly improved breadth and potency, BiIA-SG will hopefully be the first "Made in Hong Kong" anti-HIV-1 antibody drug for clinical development.
-end-
About the research team

The research was primarily conducted by the HKU team led by Professor Chen Zhiwei, Director of the AIDS Institute and Professor of Department of Microbiology. Four graduate students Xilin Wu, Jia Guo, Mengyue Niu, Ka Shing Lam and Research assistant professor Dr Li Liu of Department of Microbiology made major contributions. Key external collaborators include Dr Hui Wang at Shenzhen Third People's Hospital, Professor Hong Shang at The First Affiliated Hospital of China Medical University, Professor Xia Jin and Professor Paul Zhou at Institut Pasteur of Shanghai of Chinese Academy of Sciences, and Professor Linqi Zhang at Tsinghua University.

The work was supported by the Hong Kong RGC/NSFC (N_HKU709/11), HMRF(12110952), RGC(HKU5/CRF/13G), ITF(ITS/170/17), China's National Science and Technology Major Project (2013ZX10001005002001), National Natural Science Foundation Award (81530065), Grand Challenge China (81661128042), the Sanming Project of Medicine in Shenzhen, HKU University Development Fund and The Li Ka Shing Faculty of Medicine Matching Fund to the HKU AIDS Institute, for financial supports.

The University of Hong Kong

Related Hiv/aids Articles:

Cost-effectiveness of HIV/AIDS interventions in South Africa
An international African collaboration has turned to statistical analysis to determine the cost effectiveness of major HIV/AIDS interventions in South Africa with a view to advising policy makers on the optimal approach to managing the disease.
NY State Department of Health AIDS Institute funds HIV/AIDS prevention in high-risk youth
NewYork-Presbyterian's Comprehensive Health Program and Project STAY, an initiative of the Harlem Heath Promotion Center (HHPC) at Columbia University's Mailman School of Public Health has received two grants totaling more than $3.75 million from the New York State Department of Health AIDS Institute for their continued efforts to prevent HIV/AIDS in at-risk youth.
New research could help improve HIV/AIDS therapies
Reporting in the Feb. 18 issue of the journal Nature, University of Minnesota Hideki Aihara, Zhiqi Yin, and Ke Shi researchers, along with colleagues from Cornell University and St.
HIV/AIDS deaths are down in South Africa -- But most are still unacknowledged
After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society.
HIV particles do not cause AIDS, our own immune cells do
Scientists from the Gladstone Institutes have discovered that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.
Targeting HIV in semen to shut down AIDS
There may be two new ways to fight AIDS -- using a heat shock protein or a small molecule -- to attack fibrils in semen associated with HIV during the initial phases of infection.
Six questions about HIV/AIDS that deserve more attention
As HIV investigators work to control and eradicate the virus worldwide, certain myths or misconceptions about the disease have been embraced, whereas other concepts with merit have been left relatively unexplored, argues American HIV/AIDS researcher Jay Levy, M.D., in a Trends in Molecular Medicine commentary.
How llamas' unusual antibodies might help in the fight against HIV/AIDS
Most vaccines work by inducing an immune response characterized by neutralizing antibodies against the respective pathogen.
Research suggests ability of HIV to cause AIDS is slowing
The rapid evolution of HIV, which has allowed the virus to develop resistance to patients' natural immunity, is at the same time slowing the virus's ability to cause AIDS, according to new research funded by the Wellcome Trust.
Aging with HIV and AIDS: A growing social issue
As the first people with HIV grow old, a new study from St.

Related Hiv/aids Reading:

HIV & AIDS: A Very Short Introduction (Very Short Introductions)
by Alan Whiteside (Author)

The Origins of AIDS
by Jacques Pepin (Author)

100 Questions & Answers About HIV and AIDS
by Joel E. Gallant (Author)

AIDS at 30: A History
by Potomac Books Inc.

HIV & AIDS: The Ultimate Guide To Living With HIV And AIDS: (aids orphans, aids history, aids epidemic, aids africa, aids inc, hiv aids, health fitness ... and memoirs, 20th century american history)

Hiv/Aids: A Guide to Primary Care
by Peter J. Ungvarski MS RN ACRN FAAN (Author), Jacquelyn Haak Flaskerud PhD RN FAAN (Author)

2018 ADULT HIV/AIDS TREATMENT POCKET GUIDE (2018 edition)
by John G Bartlett (Author), Paul A Pham (Author)

HIV/AIDS: A Very Short Introduction (Very Short Introductions)
by Alan Whiteside (Author)

100 Questions & Answers About HIV and AIDS
by Joel E. Gallant (Author)

Taking Turns: Stories from HIV/AIDS Care Unit 371 (Graphic Medicine)
by MK Czerwiec (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Story Behind The Numbers
Is life today better than ever before? Does the data bear that out? This hour, TED speakers explore the stories we tell with numbers — and whether those stories portray the full picture. Guests include psychologist Steven Pinker, economists Tyler Cowen and Michael Green, journalist Hanna Rosin, and environmental activist Paul Gilding.
Now Playing: Science for the People

#487 Knitting in PEARL
This week we're discussing math and things made from yarn. We welcome mathematician Daina Taimina to the show to discuss her book "Crocheting Adventures with Hyperbolic Planes: Tactile Mathematics, Art and Craft for all to Explore", and how making geometric models that people can play with helps teach math. And we speak with research scientist Janelle Shane about her hobby of training neural networks to do things like name colours, come up with Halloween costume ideas, and generate knitting patterns: often with hilarious results. Related links: Crocheting the Hyperbolic Plane by Daina Taimina and David Henderson Daina's Hyperbolic Crochet blog...